New Study: Celexa & Zoloft Disrupt Unborn Baby Bone Growth

topamax_birth_defects_topamax_lawsuit_settlementsCelexa and Zoloft, two drugs used to treat depression, are linked to many types of birth defects. And according to a recently published study, these two antidepressants are now linked to poor bone development.

The study, Citalopram and sertraline exposure compromises embryonic bone development, appeared in Molecular Psychiatry in September 2015.

The researchers looked at bone development in zebrafish embryos and human adult stem cells.

In both cases, they discovered that exposure to either Celexa (citalopram) or Zoloft (sertraline) resulted in inhibited bone growth.

In concluding their findings, the researchers emphasized that, “[t]hese results highlight the need to further investigate the risks of SSRI use during pregnancy in exposing unborn babies to potential skeletal abnormalities.”

WE CAN HELP YOU

Do you have questions about use of antidepressants like Celexa and Zoloft during pregnancy?

If so, contact the law offices of Carey Danis & Lowe. Our team includes experienced trial attorneys and medical professionals, who are both available to answer your questions and discuss your concerns.

If you used a selective serotonin reuptake inhibitor (SSRI) antidepressant, such as Celexa or Zoloft, during your pregnancy, and your child was born with birth defects, we encourage you to contact one of our SSRI birth defect lawyers today.

We offer free case evaluations, and can help you decide whether filing a Celexa or Zoloft birth defect lawsuit is right for you and your family.

Contact Carey Danis & Lowe today.

You can reach us by phone at 800.721.2519, or by completing a confidential personal injury claim form.

 

 

References: Pharmaceutical litigation, Zoloft
Tags: , , , ,